Neumora Therapeutics (NasdaqGS:NMRA) FY Conference Transcript

Neumora Therapeutics (NasdaqGS:NMRA) FY Conference September 09, 2025 01:00 PM ET Speaker0Okay. Now we'll get started. Welcome, everybody. I'm Doug South, senior analyst at H. C.Wainwright. We are thrilled now to have Nomura with us, represented by the company's CEO, Paul Burns, company's president, Josh Pinto, and Nick Brandon from clinical the VP. Mhmm. CSO. CSO.Not enough coffee this morning. So with that, why don't we sort of start off with a lot has happened with the company in the last twelve months, ...